IL27 and HIV infectious disease: During HIV infection, this process is related to IL-27's ability to upregulate a subset of ISGs independently of IFN-I (41) and to promote a number of anti-HIV molecules (60, 61); however, we show here that, at least when used in vitro, IL-27 appears to have no restrictive effect in LCMV growth, making this hypothesis less likely.